相关实验视频
Updated: Jun 28, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
在老年患者中使用抗高血压药物的时间模式. 心血管健康研究研究
B M Psaty1, P J Savage, G S Tell
1Department of Medicine, University of Washington, Seattle.
JAMA
|October 20, 1993
概括
在老年人中,新治疗的高血压发病率为5.2-5.6%. 医生越来越多地为高血压治疗开出新的药物,如ACE抑制剂和通道阻断剂,而不是老的药物,如利尿剂和β-阻断剂.
科学领域:
- 老年学是一门学科.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血压是老年人中普遍存在的疾病.
- 了解治疗模式对于管理老年人的心血管健康至关重要.
研究的目的:
- 估计65岁及以上人群新治疗高血压的发病率.
- 描述这个人口群体中使用抗高血压药物的模式.
主要方法:
- 前性队列研究 (心血管健康研究) 涉及5201名社区居住的老年人.
- 通过标准化问卷,血压测量和药物库存在基线和1年随访时收集的数据.
- 排除缺乏数据的参与者,失去随访,或药物治疗的非高血压迹象.
主要成果:
- 新治疗高血压的年均发病率为女性5.2%,男性5.6%.
- 在1年内,抗高血压治疗的患病率略有增加,从40.7%增加到41.1% (女性),从37.1%增加到38.2% (男性).
- 与之前接受治疗的患者相比,新治疗的患者接受利尿剂或β抑制剂的可能性较小,并且更有可能接受通道阻断剂或血管酶转化酶抑制剂.
结论:
- 医生越来越倾向于使用血管酶转化酶抑制剂和通道阻断剂来治疗老年人的高血压.
- 这一转变代表了处方模式的变化,远离了利尿剂和β-阻断剂.
- 这些发现突出了在老年人群中管理高血压的不断发展的治疗策略.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...